Conditions for high-performance liquid chromatography-tandem mass spectrometry analysis
Compound | Mass Transition | Column | Initial Conditionsa | Final Conditionsa | Retention Time |
|---|---|---|---|---|---|
| min | |||||
| Alovudine | 245.1→126.9 | Atlantis C18 5 × 2.1, 5 μb | A 95%, B 5% | A 10%, B 90% | 1.04 |
| R,S-Apomorphine | 268.3→191.1 | Atlantis C18 5 × 2.1, 5 μb | A 95%, B 5% | A 10%, B 90% | 1.17 |
| R,S-Cetirizine | 389.2→200.9 | Atlantis C18 5 × 2.1, 5 μb | A 95%, B 5% | A 10%, B 90% | 1.70 |
| Codeine | 300.0→151.9 | Atlantis C18 5 × 2.1, 5 μb | C 100% | C 80%, B 20% | 2.05 |
| CP-122721 | 381.4→160.1 | Atlantis C18 5 × 2.1, 5 μb | A 95%, B 5% | A 10%, B 90% | 1.51 |
| Diazepam | 285.2→154.1 | Atlantis C18 5 × 2.1, 5 μb | A 95%, B 5% | A 10%, B 90% | 1.86 |
| Gabapentin | 172.2→137.1 | Atlantis C18 5 × 2.1, 5 μb | A 95%, B 5% | A 10%, B 90% | 0.88 |
| Morphine | 286.0→152.0 | Atlantis C18 5 × 2.1, 5 μb | A 95%, B 5% | A 10%, B 90% | 1.45 |
| M3G | 462.0→285.9 | Atlantis C18 5 × 2.1, 5 μb | C 100% | C 80%, B 20% | 1.25 |
| M6G | 462.3→286.1 | Atlantis C18 5 × 2.1, 5 μb | C 100% | C 80%, B 20% | 1.41 |
| Norfloxacin | 320.3→276.2 | Polaris C18 5 × 2, 5 μc | A 95%, B 5% | A 10%, B 90% | 1.07 |
| Oxycodone | 316.0→240.9 | Atlantis C18 5 × 2.1, 5 μb | C 100% | C 80%, B 20% | 2.01 |
| Thiopental | 241.0→100.9 | Hypurity C18 5 × 2.1, 5 μd | A 95%, B 5% | A 10%, B 90% | 1.64 |